COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults over 18 years of age
- People who have been diagnosed with moderate to very severe COPD (classified as GOLD stage II, III, or IV)
- People who have already completed a pulmonary rehabilitation program at the trial site
- People whose 6-minute walk test result was less than 350 meters, either before or after completing pulmonary rehabilitation
- People who experience significant breathlessness in daily life, rated at level 2 or higher on a standard breathlessness scale
- People whose lungs trap an excessive amount of air (a condition called pulmonary hyperinflation, confirmed by specific lung volume measurements)
- People who use supplemental oxygen or those who do not
- People whose condition has been stable for at least the last 4 weeks, with no flare-ups or changes to their treatment
- People who have never previously received a treatment called intermittent intrapulmonary deflation
- People who are affiliated with social security and have read, understood, and signed the study consent form
Who may not be able to join:
- People who are pregnant or may become pregnant
- People who are under legal guardianship or a similar protected legal arrangement
- People who are unable to give their own informed consent
- People whose primary lung diagnosis is a condition other than COPD, such as asthma or primary bronchiectasis
- People who have bone, nerve, blood vessel, or muscle conditions that affect their ability to walk, or who require a walking aid
- People with serious or unstable heart conditions, such as uncontrolled irregular heartbeat, severe heart failure, a recent heart attack, or unstable chest pain
- People who currently need assisted breathing through a tube, mask, or breathing machine, or who have a condition causing weakness in the breathing muscles, or who cannot cough strongly on their own
- People whose circulation or blood pressure is currently unstable
- People who have had a collapsed lung (pneumothorax) within the last 3 months
- People who have had surgery on their lungs or upper airways within the last month
- People who have been referred to pulmonary rehabilitation as preparation for chest surgery, such as lung volume reduction, lung transplant, or lung cancer surgery
- People who are using or plan to use an electrical or mechanical airway clearance device during the study period (such as a cough assist machine or chest oscillation vest)
- People with an active cancer diagnosis
- People who have had a severe episode of coughing up blood within the last 3 months
- People who have a severe condition causing the windpipe to collapse (severe tracheomalacia)
- People who withdraw their consent after joining
- People who experience a COPD flare-up or develop heart or breathing instability between study visits
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tristan Bonnevie, PhD, Association ADIR
Phone: 0235592970
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensory dimension of dyspnea
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.